Background Infections due to antibiotic-resistant bacteria are threatening modern health
care. However, estimating their incidence, complications, and attributable mortality is …

The new oxazolidinone antimicrobial, linezolid, has been approved for the treatment of infections
caused by various gram-positive bacteria, including meticillin-resistant Staphylococcus …

A central paradigm of immunity is that interferon (IFN)-mediated antiviral responses precede
pro-inflammatory ones, optimizing host protection and minimizing collateral damage 1 , 2 . …

Accumulating evidence points toward a very high prevalence of prolonged neurological
symptoms among coronavirus disease 2019 (COVID-19) survivors. To date, there are no …

Background Although human immunodeficiency virus (HIV)–related morbidity and mortality
rates in patients with advanced HIV infection who are treated with combination antiretroviral …

Importance Severe acute respiratory syndrome coronavirus 2 infection has evolved into a
global pandemic. Low-dose colchicine combines anti-inflammatory action with a favorable …

Scope In January 2021, the ESCMID Executive Committee decided to launch a new initiative
to develop ESCMID guidelines on several COVID-19-related issues, including treatment of …

The oxazolidinone antibiotic linezolid has demonstrated potent antimicrobial activity against
Gram-positive bacterial pathogens, including methicillin-resistant staphylococci. This article …

Tumor necrosis factor α (TNF-α) blockade has emerged as a useful therapy for collagen
vascular diseases or graft-vs-host disease. Fungal infections complicating such therapy have …

We measured SARS-CoV-2 RNA load in raw wastewater in Attica, Greece, by RT-qPCR for
the environmental surveillance of COVID-19 for 6 months. The lag between RNA load and …